• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传性大疱性表皮松解症患儿特定病因的死亡风险

Cause-specific risks of childhood death in inherited epidermolysis bullosa.

作者信息

Fine Jo-David, Johnson Lorraine B, Weiner Madeline, Suchindran Chirayath

机构信息

National Epidermolysis Bullosa Registry, Nashville, TN, USA.

出版信息

J Pediatr. 2008 Feb;152(2):276-80. doi: 10.1016/j.jpeds.2007.06.039. Epub 2007 Oct 22.

DOI:10.1016/j.jpeds.2007.06.039
PMID:18206702
Abstract

OBJECTIVE

To determine the cause-specific risks of death in children with epidermolysis bullosa (EB).

STUDY DESIGN

Data were collected throughout the continental United States between 1986 and 2002 by the National EB Registry. The study design is cross-sectional (n = 3280), containing within it a nested randomly sampled longitudinal subcohort (n = 450).

RESULTS

The risk of death during infancy and childhood was greatest in junctional EB (JEB), with cumulative and conditional risks of 40% to 44.7% by age 1 in both JEB subtypes, rising to 61.8% in children with JEB, Herlitz subtype and 48.2% in those with JEB, non-Herlitz subtype (JEB-nH) by age 15. In decreasing order, sepsis, failure to thrive, and respiratory failure were the major causes of death in children with JEB, plateauing by age 2 to 6. A small minority of children with epidermolysis bullosa simplex, Dowling-Meara subtype was at risk for death by age 1 (cumulative risk, 2.8%), with sepsis and respiratory failure accounting for cumulative risks of 1.9% and 0.9%. Only a minority of children with recessive dystrophic epidermolysis bullosa, Hallopeau-Siemens subtype was at risk of death (cumulative risk = 8% by age 15). Renal failure also rarely accounted for death in children with JEB-nH.

CONCLUSIONS

Infants and children with inherited EB, particularly those with JEB, are at significant risk of death as a result of disease complications.

摘要

目的

确定大疱性表皮松解症(EB)患儿特定病因的死亡风险。

研究设计

1986年至2002年期间,美国国家EB登记处收集了美国大陆地区的数据。该研究设计为横断面研究(n = 3280),其中包含一个嵌套的随机抽样纵向亚队列(n = 450)。

结果

婴儿期和儿童期死亡风险在交界型EB(JEB)中最高,两种JEB亚型在1岁时的累积风险和条件风险均为40%至44.7%,在JEB,Herlitz亚型患儿中到15岁时升至61.8%,在JEB,非Herlitz亚型(JEB-nH)患儿中到15岁时为48.2%。按风险递减顺序,败血症、生长发育不良和呼吸衰竭是JEB患儿的主要死亡原因,在2至6岁时趋于平稳。单纯型大疱性表皮松解症,Dowling-Meara亚型的一小部分儿童在1岁时有死亡风险(累积风险为2.8%),败血症和呼吸衰竭的累积风险分别为1.9%和0.9%。只有一小部分隐性营养不良型大疱性表皮松解症,Hallopeau-Siemens亚型患儿有死亡风险(15岁时累积风险 = 8%)。肾衰竭在JEB-nH患儿中也很少导致死亡。

结论

遗传性EB的婴幼儿,尤其是JEB患儿,因疾病并发症面临显著的死亡风险。

相似文献

1
Cause-specific risks of childhood death in inherited epidermolysis bullosa.遗传性大疱性表皮松解症患儿特定病因的死亡风险
J Pediatr. 2008 Feb;152(2):276-80. doi: 10.1016/j.jpeds.2007.06.039. Epub 2007 Oct 22.
2
Inherited epidermolysis bullosa and the risk of death from renal disease: experience of the National Epidermolysis Bullosa Registry.遗传性大疱性表皮松解症与肾病死亡风险:国家大疱性表皮松解症登记处的经验
Am J Kidney Dis. 2004 Oct;44(4):651-60.
3
Tracheolaryngeal complications of inherited epidermolysis bullosa: cumulative experience of the national epidermolysis bullosa registry.遗传性大疱性表皮松解症的气管喉并发症:国家大疱性表皮松解症登记处的累积经验
Laryngoscope. 2007 Sep;117(9):1652-60. doi: 10.1097/MLG.0b013e318093ed8e.
4
Epidemiology of epidermolysis bullosa in the antipodes: the Australasian Epidermolysis Bullosa Registry with a focus on Herlitz junctional epidermolysis bullosa.澳大拉西亚地区大疱性表皮松解症的流行病学:以澳大利亚大疱性表皮松解症登记处为重点,聚焦于赫利茨交界型大疱性表皮松解症。
Arch Dermatol. 2010 Jun;146(6):635-40. doi: 10.1001/archdermatol.2010.109.
5
Eye involvement in inherited epidermolysis bullosa: experience of the National Epidermolysis Bullosa Registry.遗传性大疱性表皮松解症的眼部受累:国家大疱性表皮松解症登记处的经验
Am J Ophthalmol. 2004 Aug;138(2):254-62. doi: 10.1016/j.ajo.2004.03.034.
6
Gastrointestinal complications of inherited epidermolysis bullosa: cumulative experience of the National Epidermolysis Bullosa Registry.遗传性大疱性表皮松解症的胃肠道并发症:国家大疱性表皮松解症登记处的累积经验
J Pediatr Gastroenterol Nutr. 2008 Feb;46(2):147-58. doi: 10.1097/MPG.0b013e31812f5667.
7
Long-term follow-up of patients with Herlitz-type junctional epidermolysis bullosa.遗传性交界型大疱性表皮松解症患者的长期随访。
Br J Dermatol. 2012 Aug;167(2):374-82. doi: 10.1111/j.1365-2133.2012.10997.x. Epub 2012 Jul 5.
8
Bone mineralization in children with epidermolysis bullosa.大疱性表皮松解症患儿的骨矿化
Br J Dermatol. 2006 May;154(5):959-62. doi: 10.1111/j.1365-2133.2005.07123.x.
9
Epidermolysis bullosa and the risk of life-threatening cancers: the National EB Registry experience, 1986-2006.大疱性表皮松解症与危及生命的癌症风险:1986 - 2006年国家大疱性表皮松解症登记处经验
J Am Acad Dermatol. 2009 Feb;60(2):203-11. doi: 10.1016/j.jaad.2008.09.035. Epub 2008 Nov 20.
10
Age and etiology of childhood epidermolysis bullosa mortality.儿童大疱性表皮松解症死亡的年龄和病因
J Dermatolog Treat. 2015 Apr;26(2):178-82. doi: 10.3109/09546634.2014.915002. Epub 2014 May 15.

引用本文的文献

1
Consensus statements for the transdisciplinary care of patients with epidermolysis bullosa in South Africa: Part 1.南非大疱性表皮松解症患者跨学科护理的共识声明:第1部分。
Health SA. 2025 Aug 6;30:2963. doi: 10.4102/hsag.v30i0.2963. eCollection 2025.
2
An Acid-Oxidising Solution Containing Hypochlorous Acid Reduces Staphylococcus aureus and Improves Bacterial Diversity in Epidermolysis Bullosa Wounds.含次氯酸的酸性氧化溶液可减少大疱性表皮松解症伤口中的金黄色葡萄球菌并改善细菌多样性。
Exp Dermatol. 2025 Aug;34(8):e70147. doi: 10.1111/exd.70147.
3
Novel readthrough agent suppresses nonsense mutations and restores functional type VII collagen and laminin 332 in epidermolysis bullosa.
新型通读剂可抑制大疱性表皮松解症中的无义突变,并恢复功能性VII型胶原蛋白和层粘连蛋白332。
Mol Ther Nucleic Acids. 2024 Sep 10;35(4):102334. doi: 10.1016/j.omtn.2024.102334. eCollection 2024 Dec 10.
4
Epidermolysis Bullosa: Two rare case reports of COL7A1 and EBS-GEN SEV KRT14 variants with review of literature.大疱性表皮松解症:COL7A1 和 EBS-GEN SEV KRT14 变体的两例罕见病例报告,并进行文献复习。
BMC Pediatr. 2024 Apr 5;24(1):242. doi: 10.1186/s12887-024-04715-0.
5
Skin Microbial Composition and Genetic Mutation Analysis in Precision Medicine for Epidermolysis Bullosa.大疱性表皮松解症精准医学中的皮肤微生物组成与基因突变分析
Curr Drug Targets. 2024;25(6):404-415. doi: 10.2174/0113894501290512240327091531.
6
Advances for pediatricians in 2022: allergy, anesthesiology, cardiology, dermatology, endocrinology, gastroenterology, genetics, global health, infectious diseases, metabolism, neonatology, neurology, oncology, pulmonology.2022 年儿科医生的进展:过敏、麻醉学、心脏病学、皮肤病学、内分泌学、胃肠病学、遗传学、全球健康、传染病、代谢、新生儿学、神经病学、肿瘤学、肺病学。
Ital J Pediatr. 2023 Sep 8;49(1):115. doi: 10.1186/s13052-023-01522-8.
7
Longitudinal study of wound healing status and bacterial colonisation of Staphylococcus aureus and Corynebacterium diphtheriae in epidermolysis bullosa patients.大疱性表皮松解症患者伤口愈合状况和金黄色葡萄球菌与白喉棒状杆菌定植的纵向研究。
Int Wound J. 2023 Mar;20(3):774-783. doi: 10.1111/iwj.13922. Epub 2022 Aug 10.
8
Stairways to Advanced Therapies for Epidermolysis Bullosa.大疱性表皮松解症的高级治疗途径
Cold Spring Harb Perspect Biol. 2023 Apr 3;15(4):a041229. doi: 10.1101/cshperspect.a041229.
9
[Beyond esthetics-Regenerative medicine for severe diseases of the adnexa oculi].超越美学——用于严重眼附属器疾病的再生医学
Ophthalmologie. 2022 Sep;119(9):878-890. doi: 10.1007/s00347-022-01643-1. Epub 2022 Jun 28.
10
Hologene 5: A Phase II/III Clinical Trial of Combined Cell and Gene Therapy of Junctional Epidermolysis Bullosa.全息 5:交界性大疱性表皮松解症细胞与基因联合治疗的 II/III 期临床试验。
Front Genet. 2021 Sep 1;12:705019. doi: 10.3389/fgene.2021.705019. eCollection 2021.